ARCA biopharma
Westminster, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MR
Michael R. BristowFounder
TA
Thomas A. KeuerExecutive
BL
Brian L. SelbyExecutive
CD
Christopher D. OzeroffNamed on SEC filing
RB
Richard B. BrewerNamed on SEC filing
JF
Jean-Francois FormelaNamed on SEC filing
LG
Linda GraisNamed on SEC filing
PM
Patrick M. WheelerNamed on SEC filing
JL
John L. ZabriskieNamed on SEC filing
BE
Burton E. SobelNamed on SEC filing
Board
DJ
Dan J. MitchellBoard director
RL
Raymond L. WoosleyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$56.5M disclosed across 3 rounds · 2011–2015
▶$51.7MraisedJun 2015 · 14 investors · PharmaceuticalsRule 506(b)
▶$51.7MraisedJun 2015 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher D. OzeroffExecutive Officer
- Thomas A. KeuerExecutive Officer
- Raymond L. WoosleyDirector
- Linda S. GraisDirector
- Dan J. MitchellDirector
- Brian L. SelbyExecutive Officer
- Robert E. ConwayDirector
- Michael R. BristowExecutive Officer, Director
- Offering amount
- $51.7M
- Amount sold
- $51.7M
- Sales commissions
- $2.6M
- Placement agents
- MTS Securities, LLC
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$326.2KraisedFeb 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$326.2KraisedFeb 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael R. BristowExecutive Officer, Director
- Robert E. ConwayDirector
- Linda S. GraisDirector
- Raymond L. WoosleyDirector
- Christopher D. OzeroffExecutive Officer
- Patrick M. WheelerExecutive Officer
- Offering amount
- $326.2K
- Amount sold
- $326.2K
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedJan 2012 · 6 investors · PharmaceuticalsRule 506(b)
▶$4.5MraisedJan 2012 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael R. BristowExecutive Officer, Director
- Richard B. BrewerDirector
- Jean-Francois FormelaDirector
- Linda GraisDirector
- Patrick M. WheelerExecutive Officer
- John L. ZabriskieDirector
- Burton E. SobelDirector
- Christopher D. OzeroffExecutive Officer
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- Sales commissions
- $97.5K
- Placement agents
- Roth Capital Partners LLC
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded ARCA biopharma?
- ARCA biopharma was founded by Michael R. Bristow.
- Who are ARCA biopharma's investors?
- ARCA biopharma's investors include Boulder Ventures.
- How much funding has ARCA biopharma raised?
- ARCA biopharma has disclosed $56.5M raised across 3 rounds.
- Where is ARCA biopharma headquartered?
- ARCA biopharma is headquartered in Westminster, US.